Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the risk of mortality. This study...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EClinicalMedicine
Hlavní autoři: Klumb, Christof, Lehmann, Thomas, Aschenbach, René, Eckardt, Niklas, Teichgräber, Ulf
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890981/
https://ncbi.nlm.nih.gov/pubmed/31832619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.09.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky